Jove
Visualize
Contact Us

Related Experiment Videos

Designing peptide vaccines for cellular cross-presentation.

P M van Endert1

  • 1Institut National de la Santé et de la Recherche Médicale Unite 25, 161 rue de Sèvres, 75015 Paris, France.

Biologicals : Journal of the International Association of Biological Standardization
|February 20, 2002
PubMed
Summary

Synthetic peptide vaccines can be improved by targeting antigen-presenting cells and optimizing intracellular processing. This enhances T-cell responses for more effective vaccine design.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Modulation of antigen presentation by autoreactive B cell clones specific for GAD65 from a type I diabetic patient.

Clinical and experimental immunology·2003
Same author

Study of antigen-processing steps reveals preferences explaining differential biological outcomes of two HLA-A2-restricted immunodominant epitopes from human immunodeficiency virus type 1.

Journal of virology·2002
Same author

Regulation of transporters associated with antigen processing (TAPs) by nucleotide binding to, and hydrolysis by, Walker consensus sequences.

Advances in experimental medicine and biology·2002
Same author

Efficient MHC class I-independent amino-terminal trimming of epitope precursor peptides in the endoplasmic reticulum.

Immunity·2001
Same author

Distinct functions of the ATP binding cassettes of transporters associated with antigen processing: a mutational analysis of Walker A and B sequences.

The Journal of biological chemistry·2001
Same author

Structural analysis of two HLA-DR-presented autoantigenic epitopes: crucial role of peripheral but not central peptide residues for T-cell receptor recognition.

Molecular immunology·2001
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Area of Science:

  • Immunology
  • Vaccinology
  • Molecular Biology

Background:

  • Synthetic peptides are cost-effective vaccine components.
  • Current peptide vaccines face limitations due to non-professional antigen-presenting cell interactions, hindering T-cell responses.

Purpose of the Study:

  • To propose modifications for peptide vaccines to enhance T-cell priming.
  • To advocate for designs that leverage cellular antigen processing mechanisms.

Main Methods:

  • Conceptual analysis of peptide-vaccine interactions.
  • Review of cellular antigen processing pathways (proteolysis, transport, HLA class I assembly).

Main Results:

  • Peptide vaccines can be engineered for selective uptake by professional antigen-presenting cells.

Related Experiment Videos

  • Exploiting intracellular processing can significantly boost T-cell stimulation.

    • Conclusions:

    • Modifying peptide vaccines for targeted uptake and optimized intracellular processing is crucial.
    • This approach promises to improve the efficiency and efficacy of peptide-based vaccines.